Registration statement for securities of certain foreign private issuers

Consolidated Statement of Cash Flows

v3.21.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities        
Loss for the period $ (75,722) $ (90,813) $ (188,030) $ (140,287)
Adjustments for:        
Finance costs 2,243 2,569 4,530 1,116
Finance income (28) (6) (610) (1,015)
Depreciation and amortization 13,322 6,459 14,487 2,496
Share-based compensation 12,344 433 9,557 7,966
Taxation (2,493) 2,937 4,639 (5,559)
Exchange loss 91 2,146 2,836 (17,075)
Gain on disposal of subsidiary (3,917)      
Impairment expense   32 6,436  
Share of net loss of associates and joint ventures accounted for using the equity method 1,276 309 1,124  
Cash flows from (used in) operations before changes in working capital (52,884) (75,934) (145,031) (152,358)
(Increase) in trade and other receivables (12,414) (8,291) 738 (9,308)
Increase/(Decrease) in trade and other payables 43,604 (3,166) 2,323 18,052
Increase/(Decrease) liabilities directly associated with the assets held for sale     1,822  
Proceeds from sale of investment in subsidiary 1,460      
Decrease in other assets/liabilities 768   (3,282)  
Net cash used in operating activities (19,466) (87,391) (143,430) (143,614)
Cash flows from investing activities        
Capital expenditure (2,444) (460) (719) (1,915)
Interest received 7 6 673 1,015
Development costs capitalized (16,254) (18,138) (36,509) (36,036)
Payment for acquisition of trade and assets     (25,671)  
Acquisition of subsidiary, net of cash acquired (13,835)      
Proceeds from sale of investment in subsidiary 2,213      
Purchase of shares in associates and joint ventures (5,000) (5,000) (10,000)  
Net cash used in investing activities (35,313) (23,592) (72,226) (36,936)
Cash flows from financing activities        
Proceeds from issuance of convertible loan notes     100,000 51,064
Repayment of convertible loans       (14,794)
Repayment of cash loan       (1,231)
Proceeds from other loans 116 357    
Payments from exercise of share options (482)      
Net proceeds from issue of share capital   1 12,096 320,334
Fees directly attributable to equity raise   (10,245) (10,245) (773)
Principle payments on leases (2,293) (782) (1,541) (1,228)
Interest paid (1,826) (2,338) (252) (851)
Net cash outflow from financing activities (4,485) (13,007) 100,058 352,521
Net (decrease) in cash and cash equivalents (59,264) (123,990) (115,598) 171,971
Cash and cash equivalents at beginning of year 101,757 214,888 214,888 46,031
Effect of exchange rate changes on cash and cash equivalents (112) (702) 2,467 (3,114)
Cash and cash equivalents at end of year 42,381 $ 90,196 $ 101,757 $ 214,888
Non-cash financing and investing activities:        
Warrants issued as consideration for acquisitions 2,340      
Conversion of Loan Agreements $ 70,000